Learn More
Abcam Butyrolactone I, ATP-competitive cyclin-dependent kinase (CDK) inhibitor, 1MG
Supplier: Abcam AB1415201MG
MW 424.4 Da, Purity >97%. Cell permeable, selective, ATP-competitive CDK inhibitor. Inhibits CDC2, CDK2, and CDK5. Inhibits the cell cycle at G1/S and G2/M. Apoptotic and antitumor activity.
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.